Novavax
NVAX
#5382
Rank
NZ$2.52 B
Marketcap
NZ$15.35
Share price
-5.85%
Change (1 day)
24.83%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: NZ$2.52 Billion

As of June 2026 Novavax has a market cap of NZ$2.52 Billion. This makes Novavax the world's 5382th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.52 B31.75%
2025NZ$1.91 B-18.51%
2024NZ$2.35 B160.83%
2023NZ$0.90 B-34.49%
2022NZ$1.37 B-91.31%
2021NZ$15.83 B60.97%
2020NZ$9.83 B5045.81%
2019NZ$0.19 B-81.87%
2018NZ$1.05 B60.9%
2017NZ$0.65 B32.84%
2016NZ$0.49 B-85.09%
2015NZ$3.30 B83.09%
2014NZ$1.80 B39.04%
2013NZ$1.30 B282.48%
2012NZ$0.33 B83.12%
2011NZ$0.18 B-46.93%
2010NZ$0.34 B-4.75%
2009NZ$0.36 B63%
2008NZ$0.22 B-16.35%
2007NZ$0.26 B-25.11%
2006NZ$0.35 B16.64%
2005NZ$0.30 B70.61%
2004NZ$0.18 B-43.61%
2003NZ$0.32 B158.3%
2002NZ$0.12 B-84.32%
2001NZ$0.79 B86.56%
2000NZ$0.42 B159.71%
1999NZ$0.16 B265.94%
1998NZ$44.61 M-56.9%
1997NZ$0.10 B99.5%
1996NZ$51.87 M

End of Day market cap according to different sources

On Jun 7th, 2026 the market cap of Novavax was reported to be:

NZ$2.68 Billion
by Nasdaq info icon info icon
NZ$2.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$481.67 B 18,976.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$252.84 B 9,914.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$489.05 B 19,269.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$175.15 B 6,837.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.83 B 12.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.85 B 52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.22 B-90.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$56.56 M-97.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$3.64 B 44.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.72 B-71.34%๐Ÿ‡บ๐Ÿ‡ธ USA